Clinical Trial Results:
Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failure
Summary
|
|
EudraCT number |
2008-006237-27 |
Trial protocol |
NL GB |
Global completion date |
08 Nov 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jan 2020
|
First version publication date |
02 Jan 2020
|
Other versions |
|
Summary report(s) |
Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c ≥ 6 % or type 2 diabetes receiving oral hypoglycaemic therapy |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.